台股 » 個股 » 神隆 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

神隆

(1789)
可現股當沖
  • 股價
    27.85
  • 漲跌
    ▲0.05
  • 漲幅
    +0.18%
  • 成交量
    515
  • 產業
    上市 生技醫療類股
  • 302人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
神隆 (1789)籌碼相關-富邦-二林 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-二林 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/2300.00228.5528.35-21,478-0.14%
2024/05/2100.001529.6029.35-151,453-1.03%
2024/05/162128.0500.0028.10211,3181.59%
2024/05/0200.00328.8028.65-31,257-0.24%
2024/04/30428.8500.0028.7041,2510.32%
2024/04/2900.00229.0029.10-21,228-0.16%
2024/04/2300.00127.5528.00-11,161-0.09%
2024/04/180.127.6000.0027.650.11,1280.00%
2024/04/12227.5000.0027.4521,0970.18%
2024/04/1000.00128.8028.70-11,040-0.10%
2024/04/08128.204428.3528.30-43962-4.47%
2024/04/03627.23127.8527.7559190.54%
2024/04/0200.002527.6927.60-25894-2.79%
2024/04/0100.00127.6027.45-1885-0.11%
2024/03/28327.8000.0027.6538210.36%
2024/03/19125.7000.0025.7516060.16%
2024/03/18525.4000.0025.4056070.82%
2024/03/14125.9500.0026.0015800.17%
2024/02/02225.4000.0025.4526300.32%
2024/01/25225.3000.0025.2527800.26%
2024/01/17425.7000.0025.6047890.51%
2023/12/21126.1500.0026.0518090.12%
2023/12/1400.00126.2526.25-1795-0.13%
2023/12/0100.00526.8426.85-5757-0.66%
2023/11/29126.6000.0026.5517290.14%
2023/11/27226.7000.0026.6027350.27%
2023/11/09125.9000.0025.9017770.13%
2023/10/261425.80125.8025.75139841.32%
2023/09/20127.6000.0027.2512,7410.04%
2023/09/1800.00127.6527.70-12,772-0.04%
2023/09/1500.00127.4027.40-12,799-0.04%
2023/09/1300.00127.0027.00-12,887-0.03%
2023/09/1200.00126.8026.80-12,968-0.03%
2023/09/0100.00227.5827.55-23,111-0.06%
2023/08/3000.00127.2027.15-13,102-0.03%
2023/08/28126.6000.0026.6013,1050.03%
2023/08/22127.0000.0027.0013,1020.03%
2023/08/183727.6900.0027.30373,0891.20%
2023/08/11128.5000.0028.5513,0530.03%
2023/08/10429.0300.0029.0543,0390.13%
2023/08/08330.8300.0030.9032,9850.10%
2023/08/0700.00231.9332.10-22,970-0.07%
2023/08/04131.8500.0031.7512,9580.03%
2023/07/27231.8000.0031.6022,8470.07%
2023/07/26132.0500.0031.6512,8390.04%
2023/07/2500.00332.7032.80-32,850-0.11%
2023/07/2400.00232.3032.10-22,862-0.07%
2023/07/21231.9000.0031.5022,8010.07%
2023/07/20531.68231.3031.3032,6860.11%
2023/07/19434.13234.6033.3522,3900.08%
2023/07/181134.52733.9533.7042,2130.18%
2023/07/17132.602.933.1333.25-1.91,891-0.10%
2023/07/1200.00129.3528.95-11,820-0.05%
2023/07/1100.00229.5029.45-21,859-0.11%
2023/07/10229.75229.5529.5001,8490.00%
2023/07/07228.5000.0028.2021,8000.11%
2023/07/03230.1300.0029.7521,7030.12%
2023/06/19229.1000.0029.0021,4100.14%
2023/06/1600.001229.0728.60-121,356-0.88%
2023/06/1500.002028.0028.05-201,274-1.57%
2023/06/1300.002027.4327.70-201,214-1.65%
2023/06/1200.001727.2026.90-171,177-1.44%
2023/06/08526.5500.0026.3551,1620.43%
2023/06/075226.6900.0026.90521,1644.47%
2023/05/2500.00126.3526.30-11,210-0.08%
2023/05/041028.6500.0028.55101,1750.85%
2023/05/0300.001028.7028.30-101,168-0.86%
2023/05/0200.00128.8028.65-11,171-0.09%
2023/04/2600.00127.2027.50-11,017-0.10%
2023/04/2400.00127.1527.05-1999-0.10%
2023/04/20127.3500.0026.9511,0180.10%
2023/04/1900.000.227.4527.30-0.21,006-0.02%
2023/04/1400.00227.1827.00-2931-0.21%
逸達前列腺癌新藥獲美藥證 神隆同步受惠Anue鉅亨-2021/05/27
〈神隆法說〉上游原物料漲幅過大 部分產品將啟動漲價Anue鉅亨-2021/05/26
〈神隆法說〉常熟廠代客研製新藥下半年放量 營運可望改善Anue鉅亨-2021/05/26
神隆 相關文章